Please use this identifier to cite or link to this item: https://open.uns.ac.rs/handle/123456789/9524
Title: Extrapyramidal syndromes caused by antipsychotics
Authors: Milana Poznić Ješić
Aleksandar Ješić
Jasmina Babović Filipović
Olga Živanović 
Keywords: Basal Ganglia Diseases;Extrapyramidal Tracts;Antipsychotic Agents;Dyskinesias;Dystonia;Psychomotor Agitation;Parkinsonian Disorders
Issue Date: 1-Jan-2012
Journal: Medicinski pregled
Abstract: INTRODUCTION: Extrapyramidal syndromes are significant side effects of antipsychotic therapy due to their severity, frequent occurrence and complications. This paper gives a brief summary of the literature with the emphasis on epidemiology, etiology, diagnosis and differential diagnosis, as well as the treatment of extrapyramidal disorders induced by antipsychotics. DYSTONIA: Sustained muscle contractions cause twisting and repetitive movements or abnormal postures. It may appear either as an acute or delayed, i.e. tardive sign. The incidence of dystonia is 2-3% among the patients treated with antipsychotics, and 50% among the ones cured with conventional antipsychotics. AKATHISIA: The main feature of this curious adverse effect is the psychomotor restlessness and the inability to remain motionless. Although akathisia is not very frequent, its incidence and prevalence ranges from 5 to 50% among the treated patients. It is most probably a result of the blockage ofdopaminergic receptors. PARKINSONISM: The most frequent secondary Parkinsonism is the one caused by drugs. The characteristic parkinsonian signs regress 4 to 16 weeks after the discontinuation of antipsychotic therapy. In the era of atypical antipsychotics this adverse effect appears less frequently. TARDIVE DYSKINESIA: Involuntary choreatic movements may appear days and months after the introduction of continuous use of antipsychotics. The individual susceptibility may play the major role in the development of this side effect. CONCLUSION: Numerous studies have compared conventional and atypical antipsychotics as well as atypical ones with one another in order to decrease the risk of development of extrapyramical side effects as well as to prevent their occurrence and improve their treatment.
URI: https://open.uns.ac.rs/handle/123456789/9524
ISSN: 258105
Appears in Collections:MDF Publikacije/Publications

Show full item record

SCOPUSTM   
Citations

15
checked on May 20, 2023

Page view(s)

28
Last Week
11
Last month
0
checked on May 10, 2024

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.